microRNA‐139‐5p confers sensitivity to antiepileptic drugs in refractory epilepsy by inhibition of MRP1
Authors:
Open Access
- 21 November 2019
- journal article
- research article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 26 (4) , 465-474
Abstract
Aim: Drug resistance is an intractable issue urgently needed to be overcome for improving efficiency of antiepileptic drugs in treating refractory epilepsy. microRNAs (miRNAs) have been proved as key regulators and therapeutic targets in epilepsy. Accordingly, the aim of the present study was to identify a novel differentially expressed miRNA which could improve the efficiency of antiepileptic drugs during the treatment of refractory epilepsy.Methods and Results: Serum samples were collected from children with refractory epilepsy. An in vivo refractory epilepsy model was developed in SD rats by electrical amygdala kindling. We identified that miR‐139‐5p was decreased and multidrug resistance‐associated protein 1 (MRP1) was remarkably upregulated in the serum samples from children with refractory epilepsy and the brain tissues from rat models of refractory epilepsy. After phenobarbitone injection in rat models of refractory epilepsy, the after discharging threshold in kindled amygdala was detected to screen out drug‐resistant rats. Dual‐luciferase reporter gene assay demonstrated that MRP1 was a target of miR‐139‐5p. In order to evaluate the effect of miR‐139‐5p/MRP1 axis on drug resistance of refractory epilepsy, we transfected plasmids into the hippocampus of drug‐resistant rats to alter the expression of miR‐139‐5p and MRP1. TUNEL staining and Nissl staining showed that miR‐139‐5p overexpression or MRP1 downregulation could reduce the apoptosis and promote survival of neurons, accompanied by alleviated neuronal damage.Conclusion: Collectively, these results suggest an important role of miR‐139‐5p/MRP1 axis in reducing the resistance of refractory epilepsy to antiepileptic drugs.Keywords
This publication has 45 references indexed in Scilit:
- Epilepsy and microRNANeuroscience, 2013
- Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal FluidFrontiers in Genetics, 2013
- Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune responseCellular and Molecular Life Sciences, 2012
- Incidence of epilepsyNeurology, 2011
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- Estimation of the burden of active and life‐time epilepsy: A meta‐analytic approachEpilepsia, 2010
- Validation of the 2-????Ct Calculation as an Alternate Method of Data Analysis for Quantitative PCR of BCR-ABL P210 TranscriptsDiagnostic Molecular Pathology, 2006
- Expression of Multidrug Transporters MRP1, MRP2, and BCRP Shortly after Status Epilepticus, during the Latent Period, and in Chronic Epileptic RatsEpilepsia, 2005
- Mechanisms of antiepileptic drug resistanceCurrent Opinion in Neurology, 2003
- Identification of Novel Genes Coding for Small Expressed RNAsScience, 2001